Currently, the research on epigenetics involving EZH2, DNA methyl transferases (DNMTs), as well as histone methyl transferases (HMTs) has absorbed increasing attention, with their corresponding inhibitors displaying great value in cancer treatment. This evidence concerns the gene EZH2 and cancer.